China’s Wu Capital leads $91.5m Series A round in genetic firm Korro Bio

China’s Wu Capital leads $91.5m Series A round in genetic firm Korro Bio

Mars W. Mosqueda Jr.

14 September, 2020

Korro BioQiming Venture Partners USAwu capital

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from World

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.